Washington Examiner
Sign in Subscribe
News
Politics
White House
Senate
House
Campaigns
Business
World
Investigations
Justice
Supreme Court
Crime
Entertainment
Washington Secrets
Policy
Defense
National Security
Energy and Environment
Education
Immigration
Finance and Economy
Healthcare
Foreign Policy
Tech
Infrastructure
Space
2026 Election
America at 250
IN FOCUS
Commentary
Columnists
Editorials
Think Tanks
Beltway Confidential
Op-Eds
Restoring America
Patriotism and Unity
Faith, Freedom, and Self-Reliance
Courage, Strength, and Optimism
Equality, Not Elitism
Community and Family
Fairness and Justice
Mission
Watch
Magazine
Magazine
Quarterly Briefing
Archives
Games
Sponsored
Protecting Air Ambulance Services
Powering Progress
ASAE – Association Leadership
National Parks
Examining Tax Reform
Fix TSCA
Inside the Corn Belt
Examining Transportation
Newsletters
Sign In Sign InHome
News
Politics
Policy2026 Election
Opinion
EditorialsOp-Eds
In FocusRestoring AmericaMagazineWatch
Sponsored
Protecting Air Ambulance ServicesPowering ProgressASAE – Association LeadershipNational ParksExamining Tax ReformFix TSCAInside the Corn BeltExamining Transportation
TWS Archive
Advertisement
Home › Tags › Posts tagged Pharmaceutical Industry

Tag: Pharmaceutical Industry

Valeant, Ackman make $45.6B Allergan bid Business

Valeant, Ackman make $45.6B Allergan bid

Washington Examiner · April 23, 2014 12:40 am
State issues restrictions for painkiller Zohydro Business

State issues restrictions for painkiller Zohydro

Philip Marcelo · April 22, 2014 10:56 pm
Drug firm exec gets 16 months in inside-trade case Business

Drug firm exec gets 16 months in inside-trade case

Washington Examiner · April 22, 2014 8:58 pm
FDA panel rejects combination pain pill Business

FDA panel rejects combination pain pill

Washington Examiner · April 22, 2014 6:55 pm
FILE - The Oct. 19, 2012 file photo shows a Novartis employee in a laboratory of Novartis in Prangins near Nyon, Switzerland. Swiss pharmaceutical giant Novartis AG announced a series of multibillion-dollar deals Tuesday, April 22, 2014 with other major pharmaceutical companies that it said would reduce sales but boost profitability, while affecting some 15,000 of its employees globally.  (AP Photo/Keystone, Yannick Bailly) Business

Novartis reshapes business with GSK, Lilly deals

John Heilprin · April 22, 2014 6:04 pm
Botox maker Allergan draws bid from Valeant Business

Botox maker Allergan draws bid from Valeant

KEN SWEETMATTHEW PERRONE · April 22, 2014 4:03 am
Valeant to bid for Botox maker Allergan Business

Valeant to bid for Botox maker Allergan

KEN SWEETMATTHEW PERRONE · April 22, 2014 12:08 am
Gov. Patrick: Appeal of Zohydro ruling unlikely Business

Gov. Patrick: Appeal of Zohydro ruling unlikely

Washington Examiner · April 16, 2014 9:39 pm
Judge blocks Massachusetts ban on painkiller Business

Judge blocks Massachusetts ban on painkiller

Steve LeBlanc · April 15, 2014 9:09 pm
FDA approves injectable diabetes drug from Glaxo Business

FDA approves injectable diabetes drug from Glaxo

Washington Examiner · April 15, 2014 8:49 pm
FDA OKs Merck tablet to reduce grass allergies Business

FDA OKs Merck tablet to reduce grass allergies

The Associated Press · April 15, 2014 7:15 pm
Report: Glaxo bribed doctors in Poland Business

Report: Glaxo bribed doctors in Poland

Washington Examiner · April 14, 2014 1:00 pm
Advertisement
  • ‹Previous page
  • 1
  • …
  • 136
  • 137
  • 138
  • 139
  • 140
  • …
  • 142
  • ›Next page
Page 138 of 142
Advertisement
Washington Examiner Manage Preferences

News

  • Politics
    • White House
    • Senate
    • House
    • Campaigns
  • Business
  • World
  • Investigations
  • Justice
  • Supreme Court
  • Crime
  • Washington Secrets
  • Entertainment
  • Sports

Policy

  • Defense
  • National Security
  • Energy
  • Immigration
  • Finance and Economy
  • Healthcare
  • Foreign Policy
  • Tech
  • Infrastructure
  • Space

Commentary

  • Columnists
  • Editorials
  • Think Tanks
  • Beltway Confidential
  • Op-Eds

Restoring America

  • Patriotism & Unity
  • Faith, Freedom & Self-Reliance
  • Courage, Strength & Optimism
  • Equality, Not Elitism
  • Community & Family
  • Fairness & Justice
  • Mission

Watch

  • Shows
NEWSLETTERS MAGAZINE ARCHIVE
  • Policies and Standards
  • Terms Of Service
  • Subscription Terms of Use
  • Privacy Policy
  • Your Privacy Choices
  • Transparency In Coverage
  • Advertise
  • Subscribe
  • Contact
  • Careers
  • Staff
  • About Examiner
  • Facebook
  • Twitter
© Copyright 2026. Washington Examiner. All Rights Reserved.
Advertisement